BioCentury | Oct 24, 2011
Company News

Panmira management update

Panmira Pharmaceuticals LLC , San Diego, Calif. Business: Inflammation, Pulmonary Hired: Hari Kumar as CEO, formerly CBO at Amira Pharmaceuticals Inc. , which Bristol-Myers Squibb Co. acquired WIR Staff...
BioCentury | Oct 10, 2011
Finance

Venture's stress

...NASDAQ:NVAX) 1987 IPO in Dec 1995; Prospect invested in a private placement in Feb 2006 Panmira Pharmaceuticals LLC...
BioCentury | Sep 12, 2011
Company News

Amira, Bristol-Myers deal

...pharma. Additionally, the pharma spun out two companies with assets from Amira: FLAP LLC; and Panmira Pharmaceuticals LLC...
...FLAP inhibitors - GSK2190915 ( AM803 ) - is in Phase II testing for asthma. Panmira...
BioCentury | Sep 10, 2011
Company News

Bristol-Myers spins out Amira assets

...created two newcos with assets from recently acquired inflammation company Amira Pharmaceuticals Inc. The first, Panmira Pharmaceuticals LLC...
Items per page:
1 - 4 of 4
BioCentury | Oct 24, 2011
Company News

Panmira management update

Panmira Pharmaceuticals LLC , San Diego, Calif. Business: Inflammation, Pulmonary Hired: Hari Kumar as CEO, formerly CBO at Amira Pharmaceuticals Inc. , which Bristol-Myers Squibb Co. acquired WIR Staff...
BioCentury | Oct 10, 2011
Finance

Venture's stress

...NASDAQ:NVAX) 1987 IPO in Dec 1995; Prospect invested in a private placement in Feb 2006 Panmira Pharmaceuticals LLC...
BioCentury | Sep 12, 2011
Company News

Amira, Bristol-Myers deal

...pharma. Additionally, the pharma spun out two companies with assets from Amira: FLAP LLC; and Panmira Pharmaceuticals LLC...
...FLAP inhibitors - GSK2190915 ( AM803 ) - is in Phase II testing for asthma. Panmira...
BioCentury | Sep 10, 2011
Company News

Bristol-Myers spins out Amira assets

...created two newcos with assets from recently acquired inflammation company Amira Pharmaceuticals Inc. The first, Panmira Pharmaceuticals LLC...
Items per page:
1 - 4 of 4